The business of survival: Generic medicines at the intersection of health, policy, and structural resilience in Lebanon
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector · 2026-06 · 22 (2) · 124-129
DOI: 10.1177/17411343261442018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, online erschienen am 10.04.2026. Verfasst von Georges Hatem und 4 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lebanon has faced a series of overlapping crises, including a severe financial collapse, the pandemic, the Beirut port explosion, the removal of subsidies, electricity shortages, and, most recently, the war in Lebanon. These events have disrupted supply chains, led to currency devaluation, damaged infrastructure, and generated market instability, ultimately resulting in critical medicine shortages, price volatility, and reduced availability of essential pharmaceuticals. These crises’ compounded effects have placed immense pressure on the healthcare system and heightened population reliance on generic medicines. This study maps the pathways linking multiple crises to medicine access challenges, highlighting both direct and indirect impacts on the pharmaceutical supply. Using a structured framework, we identify key vulnerabilities and the resulting adaptations in healthcare provision. Central to the response is the strategic promotion of generic medicines as a resilience mechanism to mitigate shortages and maintain treatment continuity. Findings underscore the importance of proactive, system-level strategies to buffer health systems against multifactorial shocks. By integrating crisis mapping with targeted interventions, policymakers and healthcare providers can enhance preparedness, ensure the availability of medicine, and strengthen resilience in the face of ongoing socio-political and economic instability. This approach offers a practical model for other regions facing compounded crises that impact healthcare access.
Zitieren
APA
Hatem, G., Mouchref, K., Chaheen, M., Rachidi, S., & Awada, S. (2026). The business of survival: Generic medicines at the intersection of health, policy, and structural resilience in Lebanon. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 22(2), 124-129. https://doi.org/10.1177/17411343261442018
Vancouver
Hatem G, Mouchref K, Chaheen M, Rachidi S, Awada S. The business of survival: Generic medicines at the intersection of health, policy, and structural resilience in Lebanon. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 2026;22(2):124-129. doi:10.1177/17411343261442018
BibTeX
@article{Hatem2026,
author = {Hatem, Georges and Mouchref, Khaled and Chaheen, Mohammad and Rachidi, Samar and Awada, Sanaa},
title = {The business of survival: Generic medicines at the intersection of health, policy, and structural resilience in Lebanon},
journal = {Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector},
year = {2026},
volume = {22},
number = {2},
pages = {124--129},
doi = {10.1177/17411343261442018}
}
EUVIMED